Tower Research Capital (TRC)’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $407K | Buy |
26,300
+13,700
| +109% | +$212K | 0.01% | 1159 |
|
2025
Q1 | $187K | Sell |
12,600
-8,298
| -40% | -$123K | 0.01% | 1413 |
|
2024
Q4 | $277K | Buy |
20,898
+16,826
| +413% | +$223K | 0.01% | 1473 |
|
2024
Q3 | $57.9K | Sell |
4,072
-2,421
| -37% | -$34.4K | ﹤0.01% | 2643 |
|
2024
Q2 | $84K | Buy |
6,493
+5,233
| +415% | +$67.7K | ﹤0.01% | 2704 |
|
2024
Q1 | $17.5K | Sell |
1,260
-5,490
| -81% | -$76.3K | ﹤0.01% | 3117 |
|
2023
Q4 | $96.3K | Buy |
6,750
+4,626
| +218% | +$66K | ﹤0.01% | 2669 |
|
2023
Q3 | $32.9K | Sell |
2,124
-242
| -10% | -$3.74K | ﹤0.01% | 2949 |
|
2023
Q2 | $37.2K | Sell |
2,366
-470
| -17% | -$7.38K | ﹤0.01% | 2811 |
|
2023
Q1 | $47K | Buy |
2,836
+527
| +23% | +$8.73K | ﹤0.01% | 2555 |
|
2022
Q4 | $36K | Buy |
+2,309
| New | +$36K | ﹤0.01% | 2594 |
|
2022
Q3 | – | Sell |
-11,938
| Closed | -$168K | – | 6476 |
|
2022
Q2 | $168K | Buy |
11,938
+8,184
| +218% | +$115K | ﹤0.01% | 1906 |
|
2022
Q1 | $54K | Buy |
+3,754
| New | +$54K | ﹤0.01% | 2671 |
|
2021
Q3 | – | Sell |
-10,165
| Closed | -$171K | – | 6158 |
|
2021
Q2 | $171K | Sell |
10,165
-13,810
| -58% | -$232K | ﹤0.01% | 2035 |
|
2021
Q1 | $438K | Buy |
23,975
+23,775
| +11,888% | +$434K | 0.01% | 1351 |
|
2020
Q4 | $4K | Sell |
200
-450
| -69% | -$9K | ﹤0.01% | 4730 |
|
2020
Q3 | $12K | Sell |
650
-1,792
| -73% | -$33.1K | ﹤0.01% | 4033 |
|
2020
Q2 | $44K | Buy |
2,442
+2,427
| +16,180% | +$43.7K | ﹤0.01% | 3144 |
|
2020
Q1 | $0 | Sell |
15
-10,396
| -100% | – | ﹤0.01% | 3861 |
|
2019
Q4 | $205K | Buy |
+10,411
| New | +$205K | 0.02% | 568 |
|
2019
Q3 | – | Sell |
-1,898
| Closed | -$34K | – | 4500 |
|
2019
Q2 | $34K | Buy |
1,898
+1,858
| +4,645% | +$33.3K | ﹤0.01% | 1832 |
|
2019
Q1 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 3627 |
|